No CrossRef data available.
Article contents
Fluoxetine–terfenadine and sexual dysfunction
Published online by Cambridge University Press: 03 January 2018
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Columns
- Information
- Copyright
- Copyright © 1998 The Royal College of Psychiatrists
References
Alzenberg, D., Zamishlany, Z. & Weizman, A. (1995) Cyproheptadine treatment of sexual dysfunction induced by SSRI. Clinical Neuropharmacology, 18, 320–324.CrossRefGoogle Scholar
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). Washington, DC: APA.Google Scholar
Labatte, L. A. & Pollack, M. H. (1994) Treatment of fluoxetine induced sexual dysfunction with bupropion: a case report. Annals of Clinical Psychiatry, 6, 13–15.CrossRefGoogle Scholar
Marchiando, R. J., Cook, M. D. & Jue, S. G. (1995) Probable terfenadine–fluoxetine associated cardiac toxicity (letter). Annals of Pharmacotherapy, 29, 937–938.CrossRefGoogle Scholar
Nemeroff, C. B., DaVane, C. L. & Pollock, B. G. (1996) Newer antidepressants and the cytochrome P450 system. American Journal of Psychiatry, 153, 311–320.Google Scholar
You have
Access
eLetters
No eLetters have been published for this article.